{"filing":{"accession_number":"0001193125-26-232722","cik":"0001585608","ticker":"JAGX","company_name":"Jaguar Health, Inc.","form":"8-K","filing_date":"2026-05-20","report_date":null,"primary_document":"d143790d8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1585608/000119312526232722/d143790d8k.htm"},"events":[{"id":9815,"run_id":8607,"accession_number":"0001193125-26-232722","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"The filing discloses a press release announcing first quarter 2026 financial results under Item 2.02 (Results of Operations and Financial Condition), which is the standard Item for earnings releases. The explicit reference to \"issued a press release announcing the first quarter 2026 results\" and attachment as Exhibit 99.1 confirms this is a periodic earnings disclosure.","company_name":"Jaguar Health, Inc.","ticker":"JAGX","filing_date":"2026-05-20","form":"8-K","submitted_at":null,"items":[{"id":622,"accession_number":"0001193125-26-232722","item_number":"2.02","item_title":null,"event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"The filing discloses a press release announcing first quarter 2026 financial results under Item 2.02 (Results of Operations and Financial Condition), which is the standard Item for earnings releases. The explicit reference to \"issued a press release announcing the first quarter 2026 results\" and attachment as Exhibit 99.1 confirms this is a periodic earnings disclosure.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-21T02:48:31.349170+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":622,"accession_number":"0001193125-26-232722","item_number":"2.02","item_title":null,"event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"The filing discloses a press release announcing first quarter 2026 financial results under Item 2.02 (Results of Operations and Financial Condition), which is the standard Item for earnings releases. The explicit reference to \"issued a press release announcing the first quarter 2026 results\" and attachment as Exhibit 99.1 confirms this is a periodic earnings disclosure.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-21T02:48:31.349170+00:00","company_name":"Jaguar Health, Inc.","ticker":"JAGX","filing_date":"2026-05-20"}]}